YTEN News and Press, Yield10 Bioscience Inc. From 01/11/23

WOBURN, Mass., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that it has signed with Mitsubishi Corporation (“Mitsubishi”) a Memorandum of Underst...

WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the C...

Yield10 Bioscience, Inc. (YTEN) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Lynne Brum – Vice President of Planning and Corporate Communications Oliver Peoples – President and Chief Executive Officer Kristi Sne...

The following slide deck was published by Yield10 Bioscience, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Yield10 Bioscience, Inc. 2022 Q3 - Results - Earnings Call Presentation

Yield10 Bioscience press release ( NASDAQ: YTEN ): Q3 GAAP EPS of -$0.71 misses by $0.05 . Revenue of $0.1M (+11.1% Y/Y) misses by $0.03M . The company continues to estimate total net cash usage for the full year ended December 31, 2022 in a range of $12.0 - $1...

-Grower contracts in place for winter 2022/2023 -Development of herbicide tolerance traits in Camelina on track -Collaboration with Rothamsted Research for omega-3 technology extended through 2023 -Management will host a conference call today at 4:30 p.m. (ET) to revie...

Yield10 Bioscience ( NASDAQ: YTEN ) is scheduled to announce Q3 earnings results on Monday, November 14th, after market close. The consensus EPS Estimate is -$0.66 and the consensus Revenue Estimate is $0.13M. Over the last 3 months, EPS estimates have seen 0 upward ...

-Advancing development of herbicide tolerant Camelina- -Building commercial seed inventory available to growers in 2023 and beyond- WOBURN, Mass., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), a...

WOBURN, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its third quarter 2022 financial results and provide a corporate...

WOBURN, MA / ACCESSWIRE / October 6, 2022 / Yield10 Bioscience, Inc. (NASDAQ:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, has been invited to present at the MicroCap Rodeo presents: The Windy City Roundup 2022 investor conference, which is being held in-person on O...